ABBV ▼ -0.7% - AbbVie Inc. $ABBV - AbbVie and Iambic Announce Collaboration to Accelerate AI-driven Drug Discovery AbbVie shares declined 0.7% today despite the company's announcement of a collaboration with Iambic to accelerate AI-driven drug discovery. The partnership represents a strategic effort to leverage artificial intelligence in the pharmaceutical development process, though investors appear to have reacted cautiously to the news. 21-SEP-2026 08:01 AM ET